If you or a loved one has had a kidney stone at a young age, or have had repeated or multiple stones, known as recurrent kidney stones, or RKS—it’s important to find out why.
Kidney stones may be caused by genes passed down at birth, and the sooner you know, the better. It is important to get a proper and timely diagnosis so that appropriate management can be initiated.
Sponsored by Novo Nordisk, NovoDETECT™ is a no-charge diagnostic testing and genetic counseling service that can help guide you and your healthcare provider in managing genetic kidney stone diseases, including PH. You, your healthcare provider, or your health insurance provider will not be billed for this program.
Testing is provided through Blueprint Genetics and Quest Diagnostics, offering both genetic and PH-specific metabolite testing—important tools that help find the root cause of early-onset or recurrent kidney stones.
Genetic testing looks for changes (mutations) in genes that may cause kidney stones to form.
Genetic testing can also have an inconclusive result, called a variant of unknown significance (VUS), when this occurs in the genes associated with PH, NovoDETECT™ uses further testing to help clarify the results.
No patient-identifiable information or data will be shared outside of the program. Examples of de-identified patient data are clinical diagnosis, age range, sex, and genetic variants associated with kidney stone diseases. Your healthcare provider’s contact information may be shared as needed.
No samples or identifiable research data will be shared with third parties without your express permission.
NovoDETECT™ should not affect treatment choice. Your healthcare provider and you will make the ultimate decision on your care. The full range of treatment options should always be considered before determining those that may be most appropriate for you.
Take a closer look at how PH is inherited.
Learn about current management options.
Novo Nordisk is committed to helping find the root cause of early-onset kidney stones or RKS through diagnostic testing, including reducing delays in diagnosis of PH.
Talk to your healthcare provider about next steps.